FDA Drug Application (021025) for EXELON by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021025
Product Number001
FormSOLUTION;ORAL
DosageEQ 2MG BASE/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEXELON
Active IngredientRIVASTIGMINE TARTRATE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.